{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:37:54Z","timestamp":1793893074945,"version":"4.8.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Fluoroquinolones (FQs) have been linked to various neuropsychiatric effects, including nightmares, mostly through case reports. However, data on nightmares remain limited and underreported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To review the literature on FQ-related nightmares and estimate the risk of nightmares associated with FQs compared to other antibiotics using data from the Food and Drug Administration Adverse Event Reporting System (FAERS) database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A literature review was conducted to identify studies on FQ-related nightmares. Active-comparator restricted disproportionality analyses were performed in FAERS (2004Q1\u20132023Q4) for ciprofloxacin, levofloxacin, and moxifloxacin compared to azithromycin and trimethoprim-sulfamethoxazole. We calculated reporting odds ratios (RORs), proportional reporting ratios, adjusted ROR (accounting age, sex, weight, and specific indications), and information components (IC\n                      <jats:sub>025<\/jats:sub>\n                      ) to detect safety signals for the Medical Dictionary for Regulatory Activities term \u201cnightmare.\u201d\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The review identified seven studies, with the prevalence of nightmares ranging from 0.01% to 8% across three trials. Disproportionality analyses indicated that FQ-associated nightmare reports were 6- to 10-fold higher than those linked to azithromycin (ROR: 6.18, 95% CI: 4.14\u20139.23) and trimethoprim-sulfamethoxazole (ROR: 10.38, 95% CI: 4.92\u201321.89), largely reported by consumers. These findings were consistent across frequentist and Bayesian methods and adjusted analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>FQs may increase the risk of nightmares. Our findings provide valuable insights for future research on their safety profile. Further research is needed to validate these findings and guide safe FQ use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251344684","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:29:48Z","timestamp":1751023788000},"page":"782-789","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-0699","authenticated-orcid":false,"given":"Mohammad Ali","family":"Omrani","sequence":"first","affiliation":[{"name":"Department of Physiology and Pharmacology, Western University, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T","family":"Tsobo","sequence":"additional","affiliation":[{"name":"Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niaz","family":"Chalabianloo","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Western University, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"ICES Western, London, ON, Canada"},{"name":"Department of Epidemiology and Biostatistics, Western University, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh S","family":"Abdullah","sequence":"additional","affiliation":[{"name":"ICES Western, London, ON, Canada"},{"name":"Lawson Health Research Institute, London Health Sciences Center, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-6564","authenticated-orcid":false,"given":"Flory T","family":"Muanda","sequence":"additional","affiliation":[{"name":"Unit of Clinical Pharmacology and Pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of the Congo"},{"name":"ICES Western, London, ON, Canada"},{"name":"Department of Epidemiology and Biostatistics, Western University, London, ON, Canada"},{"name":"Lawson Health Research Institute, London Health Sciences Center, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15178"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2024-3-3"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2021.035"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01661311"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.10.1778"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.44757"},{"key":"e_1_3_2_8_1","first-page":"918","article-title":"Nightmare due to ciprofloxacin in young patients","volume":"32","author":"Dey S","year":"1995","unstructured":"Dey S (1995) Nightmare due to ciprofloxacin in young patients. Indian Pediatr 32: 918\u2013918.","journal-title":"Indian Pediatr"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_3_2_10_1","unstructured":"FAERS US Food and Drug Administration (2024) FDA Adverse Event Reporting System (FAERS) public dashboard. Available at: https:\/\/open.fda.gov\/ (accessed 10 October)."},{"key":"e_1_3_2_11_1","unstructured":"FDA (2013) Levofloxacin (Product Monograph). Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/020634s065 020635s071 021721s032lbl.pdf (accessed 14 October 2013)."},{"key":"e_1_3_2_12_1","unstructured":"FDA (2016a) Ciprofloxacin (Product Monograph). Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/019537s086lbl.pdf (accessed 13 October 2016)."},{"key":"e_1_3_2_13_1","unstructured":"FDA (2016b) Moxifloxacin (Product Monograph). Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/021085s063lbl.pdf (accessed 12 October 2016)."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121843"},{"key":"e_1_3_2_15_1","unstructured":"Health National Institutes of Health (n.d.) RxNorm \u2013 National Library of Medicine. U.S. National Library of Medicine. Available at: https:\/\/www.nlm.nih.gov\/research\/umls\/rxnorm\/index.html (accessed 16 October 2024)."},{"key":"e_1_3_2_16_1","unstructured":"HealthCanada (2017) Summary safety review \u2013 fluoroquinolones \u2013 assessing the potential risk of persistent and disabling side effects. Available at: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/safety-reviews\/summary-safety-review-fluoroquinolones-assessing-potential-risk-persistent-disabling-effects.html (accessed 15 October)."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.3233\/978-1-61499-564-7-574"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990820)88:4<329::AID-AJMG8>3.0.CO;2-E"},{"key":"e_1_3_2_19_1","first-page":"589","article-title":"Prevalence of sleep disturbances among young adults in three European countries","volume":"18","author":"Janson C","year":"1995","unstructured":"Janson C, Gislason T, Backer WD, et al. (1995) Prevalence of sleep disturbances among young adults in three European countries. Sleep 18: 589\u2013597.","journal-title":"Sleep"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocv153"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.12788\/jcso.0167"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1997.8137"},{"key":"e_1_3_2_23_1","first-page":"864789","article-title":"Safety of fluoroquinolones: An update","volume":"13","author":"Mandell L","year":"2002","unstructured":"Mandell L, Tillotson G (2002) Safety of fluoroquinolones: An update. Canad J Infect Dis Med Microbiol 13: 864789.","journal-title":"Canad J Infect Dis Med Microbiol"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.39762"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.06.022"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2017.03.007"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00197-13"},{"key":"e_1_3_2_28_1","unstructured":"openFDA (2024) Data Licensing. openFDA. Available at: https:\/\/open.fda.gov\/license\/ (accessed 5 October)."},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.465"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2014.04.007"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1001"},{"key":"e_1_3_2_32_1","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366: l4898.","journal-title":"BMJ"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6966.1411"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081105"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251344684","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251344684","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251344684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:12:15Z","timestamp":1777507935000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251344684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1177\/02698811251344684"],"URL":"https:\/\/doi.org\/10.1177\/02698811251344684","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}